Literature DB >> 20076936

[Surgery of hepatobiliary tumors].

U Bork1, M Koch, M W Büchler, J Weitz.   

Abstract

Surgical R0 resection of primary and secondary hepatobiliary tumors, such as colorectal liver metastases, hepatocellular carcinoma, cholangiocellular carcinoma and gall bladder carcinoma, remains the only potentially curative treatment option. The extent of involvement of lymph node metastases seems to be an independent prognostic factor in these tumors. The prognostic value of a systematic lymph node dissection in hepatobiliary tumors still remains unclear as there is a lack of prospective randomized trials. However, local lymphadenectomy (hepatoduodenal ligament and retropancreaticoduodenal lymph nodes) can be easily performed with low mortality and morbidity rates and may be helpful in better staging of the patients. Further randomized trials are necessary in order to define the relevance of lymph node dissection in hepatobiliary surgery.

Entities:  

Mesh:

Year:  2010        PMID: 20076936     DOI: 10.1007/s00104-009-1812-y

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  42 in total

1.  Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: a prospective study.

Authors:  Daniel Jaeck; Hiroshi Nakano; Philippe Bachellier; Keiichiro Inoue; Jean-Christophe Weber; Elie Oussoultzoglou; Philippe Wolf; Marie-Pierre Chenard-Neu
Journal:  Ann Surg Oncol       Date:  2002-06       Impact factor: 5.344

Review 2.  Evolving treatment strategies for gallbladder cancer.

Authors:  Matthew T Hueman; Charles M Vollmer; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2009-06-03       Impact factor: 5.344

3.  Role of regional lymphadenectomy in different stage of gallbladder carcinoma.

Authors:  Jian-Dong Wang; Ying-Bin Liu; Zhi-Wei Quan; Song-Gang Li; Xue-Feng Wang; Jun Shen
Journal:  Hepatogastroenterology       Date:  2009 May-Jun

4.  Hepatic resection for colorectal metastases: analysis of prognostic factors.

Authors:  S Ambiru; M Miyazaki; T Isono; H Ito; K Nakagawa; H Shimizu; K Kusashio; S Furuya; N Nakajima
Journal:  Dis Colon Rectum       Date:  1999-05       Impact factor: 4.585

5.  Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement?

Authors:  René Adam; Robbert J de Haas; Dennis A Wicherts; Thomas A Aloia; Valérie Delvart; Daniel Azoulay; Henri Bismuth; Denis Castaing
Journal:  J Clin Oncol       Date:  2008-08-01       Impact factor: 44.544

6.  Synchronous hepatic metastases from colon cancer: changing treatment strategies and results of surgical intervention.

Authors:  Bridget N Fahy; Michael D'Angelica; Ronald P DeMatteo; Leslie H Blumgart; Martin R Weiser; Irina Ostrovnaya; Mithat Gonen; William R Jarnagin
Journal:  Ann Surg Oncol       Date:  2008-12-03       Impact factor: 5.344

7.  Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

Authors:  Michelle L DeOliveira; Steven C Cunningham; John L Cameron; Farin Kamangar; Jordan M Winter; Keith D Lillemoe; Michael A Choti; Charles J Yeo; Richard D Schulick
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

Review 8.  Strategies for the management of hepatocellular carcinoma.

Authors:  Myron Schwartz; Sasan Roayaie; Manousos Konstadoulakis
Journal:  Nat Clin Pract Oncol       Date:  2007-07

9.  Longterm survival after extended resections in patients with gallbladder cancer.

Authors:  Anu Behari; Sadiq S Sikora; Gajanan D Wagholikar; Ashok Kumar; Rajan Saxena; Vinay K Kapoor
Journal:  J Am Coll Surg       Date:  2003-01       Impact factor: 6.113

10.  Management of the hepatic lymph nodes during resection of liver metastases from colorectal cancer: a systematic review.

Authors:  Kurinchi S Gurusamy; Charles Imber; Brian R Davidson
Journal:  HPB Surg       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.